A prominently published study reported an improvement in mortality in acute respiratory distress syndrome (ARDS) patients who received early treatment with the paralyzing agent cisatracurium. [1] ...
Generic drug maker Meitheal Pharmaceuticals recalled one lot of cisatracurium besylate, a muscle relaxant, after what the Institute for Safe Medication Practices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results